Status:
UNKNOWN
Assessment of Injectable Medication Platforms
Lead Sponsor:
Canadian Forces Health Services Centre Ottawa
Conditions:
Overdose Antidote
Bleeding
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Background: While medical advances for in-hospital care rapidly evolve, a mainstay of effective pre-hospital care remains the ability to treat medical emergencies such as anaphylaxis, prolonged seizu...
Detailed Description
Research Objective: To understand the efficiency of injectable medication delivery in the Canadian Forces and civilian world for improved care delivery in military and pre-hospital environments. Par...
Eligibility Criteria
Inclusion
- any participant over the age of 18 able to provide consent
Exclusion
- only participants with pre specified conditions impacting cognitive and/or manual dexterity will be excluded
- recent substance use
- non health care workers injection with experience with medication injection in last 12 months
Key Trial Info
Start Date :
April 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05367531
Start Date
April 30 2022
End Date
January 1 2025
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Canadian Forces
Ottawa, Ontario, Canada, K1K 0T2